Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01
Published February 19, 2020 · Recall initiated: January 27, 2020
Summary
FDA records drug Class II recall D-0837-2020, published February 19, 2020 and initiated January 27, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 17,436 bottles; Lot: Lot # 1332799A, Exp 11/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP deviations: Product bottle may be absent of desiccant.
What to do
Voluntary: Firm initiated · Letter
Get an email if METHYLPHENIDATE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- USA Nationwide
- Lot
- Lot # 1332799A, Exp 11/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, ManufacturedJuly 10, 2024
- FDAMethylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: OhmAugust 2, 2023
- FDAMethylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: RisingMarch 2, 2022
- FDAMethylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, TevaFebruary 19, 2020
- FDAHydrocortisone and Acetic Acid Otic Solution, USP, 10 mL dropper bottle, Rx only, HI-TECH PHARMACAL CO., INC.,February 19, 2020
- FDAFentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL), 2 mL Single-dose Vial, Each Tray contains 25February 19, 2020
Questions about this recall
Was Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01 recalled?
Yes. FDA published recall D-0837-2020 on February 19, 2020. Reported hazard: CGMP deviations: Product bottle may be absent of desiccant.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHYLPHENIDATE HYDROCHLORIDE.